Matches in SemOpenAlex for { <https://semopenalex.org/work/W2108242588> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W2108242588 endingPage "412" @default.
- W2108242588 startingPage "409" @default.
- W2108242588 abstract "Idiopathic feline lower urinary tract disease (FLUTD) is a common clinical entity where different treatments, for example glycosaminoglycans (GAGs) such as pentosan polysulphate (PPS), are advocated. However, few treatments have been investigated by well-controlled clinical trials. This paper compares the use of PPS in FLUTD compared to placebo. Of the 18 cats in the experiment, nine were treated with PPS and nine were treated with placebo with subcutaneous injections of 3mg/kg PPS or placebo day 1, 2, 5 and 10. The study was double-blind, randomised and placebo-controlled. Revaluation was performed after 5 and 10 days, 2 weeks, 2, 6 and 12 months. There were no statistically significant differences concerning clinical signs between groups during treatment or at re-evaluation, except for pretreatment stressful events where PPS-treated cats had experienced significantly more stressful events compared to cats treated with placebo before entering the study. Six cats (33%) showed recurrence of clinical signs during the entire study period, and only one of these cats had more than one recurrent episode. One cat (placebo) was euthanased 7 days after initial treatment because of recurrence of clinical signs. Another cat (placebo) was euthanased due to other reasons after 6 months. At 2 weeks two cats (placebo and PPS) showed clinical signs. At 2 months re-evaluation one cat showed mild clinical signs. At 6 and 12 months all remaining 16 cats were healthy. Idiopathic, non-obstructive FLUTD is a self-limiting disease with good short-term and excellent long-term prognosis without treatment. Whether or not PPS may be beneficial in a subpopulation of cats with continuous or frequently recurring clinical signs may be elucidated in forthcoming double-blind, randomised and placebo-controlled trials including only this subpopulation of cats." @default.
- W2108242588 created "2016-06-24" @default.
- W2108242588 creator A5026020458 @default.
- W2108242588 creator A5065080353 @default.
- W2108242588 date "2009-06-01" @default.
- W2108242588 modified "2023-10-05" @default.
- W2108242588 title "Use of pentosan polysulphate in cats with idiopathic, non-obstructive lower urinary tract disease: A double-blind, randomised, placebo-controlled trial" @default.
- W2108242588 cites W153211876 @default.
- W2108242588 cites W2007069784 @default.
- W2108242588 cites W2032630018 @default.
- W2108242588 cites W2062420082 @default.
- W2108242588 cites W2069429755 @default.
- W2108242588 cites W2086494875 @default.
- W2108242588 cites W2128996083 @default.
- W2108242588 cites W2144036117 @default.
- W2108242588 cites W2155382408 @default.
- W2108242588 cites W2163786027 @default.
- W2108242588 cites W2165391777 @default.
- W2108242588 doi "https://doi.org/10.1016/j.jfms.2008.09.003" @default.
- W2108242588 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18996037" @default.
- W2108242588 hasPublicationYear "2009" @default.
- W2108242588 type Work @default.
- W2108242588 sameAs 2108242588 @default.
- W2108242588 citedByCount "24" @default.
- W2108242588 countsByYear W21082425882012 @default.
- W2108242588 countsByYear W21082425882014 @default.
- W2108242588 countsByYear W21082425882015 @default.
- W2108242588 countsByYear W21082425882016 @default.
- W2108242588 countsByYear W21082425882018 @default.
- W2108242588 countsByYear W21082425882019 @default.
- W2108242588 countsByYear W21082425882020 @default.
- W2108242588 countsByYear W21082425882021 @default.
- W2108242588 countsByYear W21082425882022 @default.
- W2108242588 countsByYear W21082425882023 @default.
- W2108242588 crossrefType "journal-article" @default.
- W2108242588 hasAuthorship W2108242588A5026020458 @default.
- W2108242588 hasAuthorship W2108242588A5065080353 @default.
- W2108242588 hasBestOaLocation W21082425881 @default.
- W2108242588 hasConcept C126322002 @default.
- W2108242588 hasConcept C141071460 @default.
- W2108242588 hasConcept C142724271 @default.
- W2108242588 hasConcept C204787440 @default.
- W2108242588 hasConcept C27081682 @default.
- W2108242588 hasConcept C2779904517 @default.
- W2108242588 hasConcept C2991744798 @default.
- W2108242588 hasConcept C535046627 @default.
- W2108242588 hasConcept C71924100 @default.
- W2108242588 hasConcept C77411442 @default.
- W2108242588 hasConceptScore W2108242588C126322002 @default.
- W2108242588 hasConceptScore W2108242588C141071460 @default.
- W2108242588 hasConceptScore W2108242588C142724271 @default.
- W2108242588 hasConceptScore W2108242588C204787440 @default.
- W2108242588 hasConceptScore W2108242588C27081682 @default.
- W2108242588 hasConceptScore W2108242588C2779904517 @default.
- W2108242588 hasConceptScore W2108242588C2991744798 @default.
- W2108242588 hasConceptScore W2108242588C535046627 @default.
- W2108242588 hasConceptScore W2108242588C71924100 @default.
- W2108242588 hasConceptScore W2108242588C77411442 @default.
- W2108242588 hasIssue "6" @default.
- W2108242588 hasLocation W21082425881 @default.
- W2108242588 hasLocation W21082425882 @default.
- W2108242588 hasOpenAccess W2108242588 @default.
- W2108242588 hasPrimaryLocation W21082425881 @default.
- W2108242588 hasRelatedWork W1586374228 @default.
- W2108242588 hasRelatedWork W2003938723 @default.
- W2108242588 hasRelatedWork W2045240138 @default.
- W2108242588 hasRelatedWork W2047967234 @default.
- W2108242588 hasRelatedWork W2118496982 @default.
- W2108242588 hasRelatedWork W2364998975 @default.
- W2108242588 hasRelatedWork W2369162477 @default.
- W2108242588 hasRelatedWork W2439875401 @default.
- W2108242588 hasRelatedWork W4238867864 @default.
- W2108242588 hasRelatedWork W2525756941 @default.
- W2108242588 hasVolume "11" @default.
- W2108242588 isParatext "false" @default.
- W2108242588 isRetracted "false" @default.
- W2108242588 magId "2108242588" @default.
- W2108242588 workType "article" @default.